Panel agrees device is safe; bare majority says it’s effective and that benefits do not outweigh risks
Medtronic’s Symplicity Spyral Renal Denervation (RDN) System is safe, members of a U.S. Food and Drug Administration (FDA) advisory panel said unanimously Wednesday, but they split on the device’s effectiveness and whether the benefits outweigh the risks.